UPR activation alters chemosensitivity of tumor cells

A growing body of literature demonstrates that the unfolded protein response (UPR) is activated in a number of tumors. Recent data suggests that the UPR may play a role in protecting transformed cells from the inadequate environment that exists prior to vascularization and therefore contribute to tu...

Full description

Saved in:
Bibliographic Details
Published in:Cancer biology & therapy 2006-07, Vol.5 (7), p.736-740
Main Authors: Mann, Melissa J., Hendershot, Linda M.
Format: Article
Language:English
Subjects:
Antineoplastic Agents - metabolism
Binding
Biology
Bioscience
Calcium
Cancer
Cell
Cycle
DNA Topoisomerases, Type II - metabolism
Drug Resistance, Neoplasm
Endoplasmic Reticulum - drug effects
Endoplasmic Reticulum - metabolism
Humans
Landes
Neoplasm Proteins - metabolism
Neoplasms - drug therapy
Neoplasms - metabolism
Organogenesis
Protein Folding
Proteins
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A growing body of literature demonstrates that the unfolded protein response (UPR) is activated in a number of tumors. Recent data suggests that the UPR may play a role in protecting transformed cells from the inadequate environment that exists prior to vascularization and therefore contribute to tumor growth and survival. In addition, data from cell culture based studies demonstrate that pharmacological activation of the UPR can alter the sensitivity of cells to chemotherapeutic agents, making them either more sensitive in some cases or more resistant in others. Thus, it will be important to understand and integrate data on the role of the UPR in tumor growth and survival with studies on the effects of UPR activation on chemosensitivity before considering therapeutic interventions into this signaling pathway.
ISSN:1538-4047
1555-8576
DOI:10.4161/cbt.5.7.2969